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Summary
 
To characterize gene expression in activated mast cells more comprehensively than heretofore,
we surveyed the changes in genetic transcripts by the method of serial analysis of gene expres-
sion in the RBL-2H3 line of rat mast cells before and after they were stimulated through their
receptors with high affinity for immunoglobulin E (Fc
 
e
 
RI). A total of 40,759 transcripts de-
rived from 11,300 genes were analyzed. Among the diverse genes that had not been previously
associated with mast cells and that were constitutively expressed were those for the cytokine
macrophage migration inhibitory factor neurohormone receptors such as growth hormone-
releasing factor and melatonin and components of the exocytotic machinery. In addition, sev-
eral dozen transcripts were differentially expressed in response to antigen-induced clustering of
the Fc
 
e
 
RI. Included among these were the genes for preprorelaxin, mitogen-activated protein
kinase kinase 3, and the dual specificity protein phosphatase, rVH6. Significantly, the majority
of genes differentially expressed in this well-studied model of mast cell activation have not been
identified before this analysis.
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allergy
ast cells perform a significant role in host defense
against parasitic and some bacterial infections (1).
They are also widely distributed in neural and endocrine
tissues and have been referred to as the “emergency kit” for
the response to stress (2). As part of their armamentarium
for host defense, they, and the closely related circulating
basophils, express large numbers of receptors having a high
affinity for IgE (Fc
 
e
 
RI) (3). A signaling cascade initiated by
aggregation of the Fc
 
e
 
RI leads to the rapid release of pre-
formed, granule-associated mediators, such as histamine,
serotonin, and proteases, and to the secretion of mem-
brane-derived arachidonic acid metabolites such as leuko-
triene C
 
4
 
 and prostaglandin D
 
2
 
 (4). These rapid responses
are followed by changes in gene expression and release of
multiple cytokines, chemokines, and other immunomodu-
latory molecules (5). Allergic reactions, mediated in part by
mast cells, involve an apparent aberration of the protective
role played by IgE and Fc
 
e
 
RI. In the allergic individual,
harmless environmental antigens evoke an anomalous IgE
response and the interaction of the IgE with the Fc
 
e
 
RI
“sensitizes” the cells so that subsequent exposure to the an-
tigen can lead to a dramatic, sometimes even fatal systemic
anaphylaxis.
Earlier studies of such events were largely concerned
with examining functional or biochemical phenomena;
more recently many genes coding for molecules thought to
be involved in the activation of mast cells have been identi-
fied and in a few instances manipulated to determine the
role of the proteins they code for. The aim of the present
investigation was to define comprehensively the profiles of
expressed genes in resting and activated mast cells in order
to discover unsuspected molecular participants in the cellu-
lar events.
We chose to use serial analysis of gene expression
(SAGE)
 
1
 
 for this purpose because it has proved to be useful
for a high throughput survey of which genes are being
transcribed (6, 7). The principles of this method are as fol-
lows: (
 
a
 
) when derived from a defined location of a tran-
script, a sequence of 
 
z
 
10 bp is sufficient to provide a
 
M
 
1
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2
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2
 
; RT, reverse
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unique “tag” for any gene from even a large, e.g., mamma-
lian, genome. (
 
b
 
) By ligating many such tags together along
with a restriction enzyme recognition sequence that acts as
a linker, a large number of such tags can be efficiently
sequenced and identified. Specifically what is done is to
convert the desired mRNA into double stranded cDNA.
These cDNAs are then digested with an endonuclease that
recognizes only the four nucleotide sequence CATG.
Consequently an average random sequence of 256 bp
should contain one such site. Separate aliquots are then li-
gated with distinctive linkers, and cleaved with a “tagging”
endonuclease that will leave a short sequence of 
 
z
 
14 bp:
the CATG and a unique 10-bp sequence. The cDNAs
containing the discrete linkers are then ligated and such
“ditags” amplified by PCR. Many such ditags are then li-
gated to form concatamers and the concatamers are inserted
into a plasmid and sequenced, the terminal CATG acting as
commas between successive ditags. Any single messenger
species should be represented by a corresponding single
species of tag at a multiplicity proportional to the multi-
plicity of that messenger species. The cells we used, RBL-
2H3 cells (8), were derived from a rat mucosal mast cell
line (9–11), and have been widely used for studying mast
cell biology.
 
Materials and Methods
 
Cells and Cell Culture.
 
Rat basophilic leukemia cells (RBL-
2H3) were maintained as described previously (8). When stimu-
lated cells were desired, the RBL-2H3 cells were sensitized over-
night with mouse anti-DNP IgE (12) at 2 
 
m
 
g/ml, washed three
times, and stimulated in culture medium with DNP
 
18
 
-BSA at a
concentration of 100 ng/ml for varying times. HMC-1 cells (13)
were grown in Iscove’s medium supplemented with 10% FCS
and 10
 
2
 
5
 
 M monothioglycerol. UK812 cells (14) were cultured
in RPMI 1640 and 15% FCS. Peritoneal mast cells and macro-
phages were purified as described (15, 16). In brief, peritoneal
cells (3 
 
3
 
 10
 
8
 
) from ten Sprague Dawley rats were harvested us-
ing Tyrode’s buffer (135 mM NaCl, 5 mM KCl, 10 mM Hepes,
and 5.6 mM glucose) with 0.1% BSA. The cells were sedimented
by centrifugation at 100 
 
g
 
 for 5 min. The cell pellets were pooled
and resuspended at a concentration of 5 
 
3
 
 10
 
7
 
 cells/ml. A 1-ml
suspension of cells was layered on a 2-ml cushion of 22.5% wt/
vol metrizamide and centrifuged at 400 
 
g
 
 for 15 min. The cells
remaining at the buffer-metrizamide interface were aspirated and
saved for preparation of macrophages. The cells in the pellet were
pooled, washed twice in Tyrode’s buffer, and determined to be
95% pure mast cells as measured by staining with 0.1% toluidine
blue. The cells collected at the interface were seeded in tissue cul-
ture flasks and incubated at 37
 
8
 
C for 3 h. After washing off non-
adherent cells, the adherent cells (macrophages) were collected.
Both mast cells and macrophages were used for preparing RNA
immediately after purification.
 
RNA and SAGE.
 
Total RNA was prepared from peritoneal
mast cells and macrophages with Trizol (GIBCO BRL, Gaithers-
burg, MD) following the manufacturer’s protocol. The isolated
total RNA from peritoneal mast cells was treated with heparinase
I (Sigma Chemical Co., St. Louis, MO) as previously described
(17) before performing reverse transcription (RT) PCR. Messenger
RNAs were purified from resting and stimulated RBL-2H3 cells
with the MessageMaker Kit (GIBCO BRL) following the manu-
facturer’s instruction. Messenger RNAs from unstimulated cells
and cells stimulated for 3.5 h (above) were used for generating the
“resting” and “activated” SAGE libraries. SAGE was performed as
described (18). Detailed protocols and sequence analysis software
were provided by Dr. Kenneth W. Kinzler (Johns Hopkins On-
cology Center, Baltimore, MD). DNA sequencing of 1,600 clones
containing concatenated tags was done using 
 
2
 
21M13 dye primer
fluorescent sequencing chemistry (PE Applied Biosystems, Foster
City, CA). Sequencing reactions were run on a 377 ABI auto-
mated sequencer. All electropherograms were reanalyzed by visual
inspection to check for ambiguous base calls and to correct mis-
reads.
 
Statistical Analysis.
 
The data were analyzed as indicated in the
Appendix.
 
RT-PCR, Northern Blot and Library Screening.
 
RT-PCR was
carried out following the manufacturer’s protocol using an RT-PCR
kit (Stratagene, La Jolla, CA). The primers we used for amplification
of the corresponding gene transcripts were: macrophage migration
inhibitory factor (MIF)(5
 
9
 
-CGGAATTCGGGTCACGTAGT-
CAGGTCCCAGACT-3
 
9
 
, 5
 
9
 
-GCTCTAGAGGTCTCAAACCA-
TTTATTTCTCCCG-3
 
9
 
); preprorelaxin (5
 
9
 
-CGGAATTCTGA-
ACCGCCCAGGAGCACCGCCCA-3
 
9
 
, 5
 
9
 
-GCTCTAGATTA-
TTAACAGAACTACAACAATGCA-3
 
9
 
); Hrs-2 (5
 
9
 
-TTG-GAG-
ACAGACTGGAGTCCATT-3
 
9
 
, 5
 
9
 
-TCCCAGCCTCCACAGA-
CCAGCAAC-3
 
9
 
); vesicle-associated membrane protein (VAMP)-2
(5
 
9
 
-TGGGAGCTTCCAACATGTTGATTA-3
 
9
 
, 5
 
9
 
-CCACAGA-
ATTGGGGGCATGGGGCA-3
 
9
 
); annexin V (5
 
9
 
-ACAGCAT-
CTGGCTCTCGAGGCA-3
 
9
 
, 5
 
9
 
-GTTCACAATTTCATGGCT-
AAGGTTCC-3
 
9
 
); gonadotropin-releasing hormone (GnRH)
receptor (5
 
9
 
-AGTGGCATTTGGCACCTCCTTTGT-3
 
9
 
, 5
 
9
 
-CCT-
AATAATCTGTGCTGTTGGTCTATA-3
 
9
 
); melatonin recep-
tor (5
 
9
 
-TACGTGTTCCTGATATGGACACTG-3
 
9
 
, 5
 
9
 
-GGC-
CGGATCTGAGGCCACAATAAG-3
 
9
 
); RMCP-5 (5
 
9
 
-AGAT-
CATCGGGGGCACGGAGTGCA-3
 
9
 
, 5
 
9
 
-AGGAACTTTCTG-
TGACTTGTAAGAACC-3
 
9
 
); TNF-
 
a
 
 (5
 
9
 
-CAAGGAGGAG-
AAGTTCCCAA-3
 
9
 
, 5
 
9
 
-CGGACTCCGTGATGTCTAAG-3
 
9
 
);
IL-3 (5
 
9
 
-GTATGCTGCTCCCGCTCCTGATG-3
 
9
 
, 5
 
9
 
-CAT-
TCCACGGTCATAGGGCGAAAG-3
 
9
 
); 
 
b
 
-actin (5
 
9
 
-GTGGGG-
CGCCCCAGGCACCA-3
 
9
 
, 5
 
9
 
-GTCCTTAATGTCACGCACG-
ATTTC-3
 
9
 
).
Northern blot analyses were performed as described (19). The
RBL-2H3 cDNA library was screened with 
 
32
 
P-labeled oligonu-
cleotides derived from clone 1 and 9 tag sequences as described (18).
 
Rabbit Anti–Rat MIF Antiserum.
 
A full-length cDNA for MIF
was amplified from resting RBL-2H3 cell mRNA by RT-PCR
using the following primers: 5
 
9
 
-CGGAATTCATGCCTATGT-
TCATCTGAACA-3
 
9
 
 and 5
 
9
 
-CCGCTCGAGTCAAGCGAAG-
GTGGAACCGTTC-3
 
9
 
. After digestion with EcoRI and XhoI,
the PCR fragment was cloned into the pGEX4T-1 vector (Phar-
macia, Piscataway, NJ). A glutathione-
 
S
 
-transferase-MIF fusion
protein was expressed in 
 
Escherichia coli
 
 and purified as described
(19). Rabbit anti–rat MIF antiserum was generated by immunizing
rabbits with the purified fusion protein following standard protocols.
 
Immunoprecipitation and Western Blots.
 
RBL-2H3, HMC-1,
and KU812 cell lysates were prepared as previously described
(20). 4 
 
m
 
g of goat anti–human MIF antibody (R&D Systems,
Minneapolis, MN) and 25 
 
m
 
l of protein G beads were added to 1
ml of lysate (3 
 
3
 
 10
 
6
 
 cell equivalents) or culture supernatants or
fresh culture medium. After incubation for 3 h, the beads were
recovered by centrifugation, and the immunoprecipitates washed
twice. Bound proteins were released by boiling in SDS sample
buffer, separated by electrophoresis in 4–20% gradient SDS- 
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Table 1.
 
Summary of SAGE Data
 
Frequency distribution
 
*
 
$
 
20 19 to 5 4 to 2
 
5
 
1
Resting cells
No. unique genes identified 131 (1.8)
 
‡
 
487 (6.8) 1,850 (25.9) 4,673 (65.4)
No. tags sequenced
 
§
 
7,015 (34.8) 3,822 (18.9) 4,667 (23.1) 4,673 (23.2)
Activated cells
No. unique genes identified 132 (1.9) 451 (6.4) 1,647 (23.3) 4,830 (68.4)
No. tags sequenced 7,938 (38.6) 3,667 (17.8) 4,147 (20.1) 4,830 (23.5)
 
*
 
The frequency distribution of a given tag identified in this analysis was calculated within a total population of 20,177 tags sequenced from resting
cells and 20,582 tags sequenced from stimulated RBL-2H3 cells.
 
‡
 
Percentage in frequency group.
 
§
 
The total number of tags identified that are derived from genes with a copy number indicated above are shown.
PAGE gels, and transferred to nitrocellulose membranes. MIF
immunoprecipitates from HMC-1 and KU812 samples were
blotted with monoclonal anti-human MIF (R&D Systems) at 0.5
 
m
 
g/ml, whereas MIF immunoprecipitates from RBL-2H3 sam-
ples were blotted with rabbit anti-rat MIF serum at 1:2,000 dilu-
tion. To detect mitogen-activated protein kinase kinase
(MAPKK3) protein, cell lysates were prepared as above from rest-
ing and activated RBL-2H3 cells at various times after stimula-
tion, and separated on 10% SDS-PAGE gels. Isoform-specific
rabbit anti-MAPKK3 antibody (Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA) was used as the primary antibody at 0.5 
 
m
 
g/ml.
 
Results
 
Methodological Aspects of SAGE Analysis and General Re-
sults.
 
We decided to compare resting cells with cells stim-
ulated through their Fc
 
e
 
RI using conditions that were pre-
viously known to give a robust response and at times where
prior studies had demonstrated active transcription of newly
activated genes (5). Messenger RNA was purified from the
activated RBL-2H3 cells and from an equivalent number
of unstimulated cells, and analyzed by SAGE. A total of
40,759 tags were generated; approximately half were from
the population of resting cells and half from the activated
cells.
We extended some of the results and validated the fidel-
ity of the SAGE analysis using RT-PCR, or Northern
blotting (with or without Western analysis). In all 16 in-
stances in which this was done, the genes identified by the
expression of the tags analyzed in this study were con-
firmed.
Approximately 7,000 distinct tags were identified in each
of the SAGE libraries separately prepared from the resting
and activated transcripts (Table 1) with the vast majority of
the distinct tags likely to correspond to unique genes. The
characteristics of the frequency distribution of expressed
genes are strikingly similar in the resting and activated cells:
the most abundant transcripts, whose levels are equal to or
 
.
 
0.1%, are derived from 
 
,
 
2% of the genes analyzed but
constitute .34% of the total transcripts. Correspondingly,
65% of the genes account for those transcripts present at
low abundance, with an average of 0.005%, and contribute
only 23% of the total transcripts (Table 1).
As expected, the number of unique genes identified was
directly proportional to the number of tags sequenced,
with a total of 11,300 unique genes identified in the com-
bined data sets of the two libraries (Fig. 1). Statistical analy-
sis (Appendix) reveals that there was a 95% chance of de-
tecting a transcript expressed at an average abundance of
.0.0075% in the RNA samples from the two populations.
Results from Unactivated Cells. Consistent with a study
in yeast (21), housekeeping genes such as those for cyto-
skeletal structures and enzymes involved in protein synthe-
sis and energy metabolism, constitute the majority of highly
expressed genes in RBL-2H3 cells. It is noteworthy that
each of the 50 most abundant housekeeping genes we
identified was represented by a unique tag thus confirming
that the vast majority of the unique tags represent discrete
transcripts. However, in one instance of a very highly ex-
pressed endogenous retrovirus-like gene, we observed a
low number of two tags that had been generated from in-
ternal sequences of the same transcript (below).
Many genes and their corresponding proteins character-
istic of mast cells, such as Fc receptors, mediators and their
synthetic enzymes, have been studied, but no systematic
Figure 1. Results of the combined analysis of two SAGE tag libraries.1660 Gene Expression in Mast Cells
quantitation of the levels of gene transcripts for these com-
ponents has been published. Table 2 lists the mRNA levels
of some representative genes characteristic of mast cells in
unstimulated RBL-2H3 cells. Consistent with a previous
study, RBL-2H3 cells, like normal mast cells, express low-
affinity Fc receptors for IgG (i.e., FcgRIIb2 and FcgRIII;
reference 22). In fact, our analysis indicates that the mRNA
levels for these two a chains are comparable to the level of
FceRI a (Table 2).
Transcripts for constituents of mast cell granules were
also identified: The proteoglycan peptide core protein
serves as a packing site to store mediators, such as hista-
mine, serotonin, and proteases, and transcripts for this pro-
tein were found to be expressed at a high level. Of the
mRNA coding for proteases, that for carboxypeptidase A
was present at a much higher level than others. This is no-
table since the older, nonsecreting RBL-1 line of these cells
has been reported to lack transcripts coding for this pro-
tease (23). The number of gene transcripts coding for histi-
dine decarboxylase, which converts histidine to histamine
(24), was tenfold higher than that for aromatic l-amino
acid decarboxylase, the enzyme that converts tryptophan to
serotonin (see Fig. 7 in reference 16). Transcripts encoding
enzymes regulating arachidonic acid metabolism (25) such
as phospholipase A2 (PLA2), which generates arachidonic
acid from phospholipids, 5-lipoxygenase, a synthetase for
the 5-HPETE intermediate for leukotrienes, glutathione-
S-transferase, responsible for the production of the leuko-
triene LTC4, and prostaglandin D2 synthetase, were ex-
pressed at low to intermediate levels.
The variation in mRNA levels for such mast cell-specific
components was notable. For example, transcripts for the
proteoglycan peptide core protein were observed 49 times,
which can be calculated to correspond to z735 copies/
cell, assuming 300,000 total transcripts per cell (Materials
and Methods). In contrast, transcripts for PLA2 and for
aromatic l-amino acid decarboxylase were observed only
once, corresponding to z15 copies/cell.
Diverse gene transcripts for proteins not previously asso-
ciated with mast cells, were found to be constitutively ex-
pressed in RBL-2H3 cells. Some of these are listed in Table
3. Among them was the macrophage migration inhibitory
factor, MIF, a proinflammatory cytokine primarily pro-
duced constitutively by the anterior pituitary and by mac-
rophages, and released in response to endotoxin (26). More
than 520 copies/cell were expressed in the RBL-2H3 cells.
Using RT-PCR, we observed that normal rat peritoneal
mast cells, like peritoneal macrophages, express MIF (Fig.
2 A). These results suggest that mast cells are a major source
of production of MIF. We did not observe the release of
MIF from resting (Fig. 2 B) or FceRI-activated RBL-2H3
cells (data not shown), whereas the human immature mast
Table 2. Expression of Transcripts Characteristic of Mast Cells Before and After Stimulation by FceRI
Tag sequence* Resting cells‡ Activated cells§ Gene
Mediators
AAACAATGTG 49 28 Proteoglycan peptide core protein
AAGTCCTGCA 25 11 Carboxypeptidase A
TGGGATCTGG 7 0 Rat mast cell protease-5
TCCGAAGACT 2 2 Rat mast cell protease-10
Mediator synthetases
CTTCAGAGGG 11 19 Histidine decarboxylase
CTACTTCTTC 5 2 5-Lipoxygenase
CCCACATAGT 3 4 S-glutathione-S-transferase
GGCAGAGGAA 1 2 Prostaglandin D2 synthetase
CGAAATAAAT 1 1 c-Phospholipase-A2
TGTGTCTCCA 1 1 Aromatic l-amino acid decarboxylase
Receptors
TTGGTTTGGG 17 10 FceRI b
CAATAAATAA 11 7 FceRI a
ATGCTCTGGA 9 5 FcgRIII a
CTAAGGAGAT 6 3 FcgRIIb2 a
CTAGGCTCTA 4 2 FceRI g
*In this and the succeeding tables, the tag sequences represent the 10-bp SAGE tags 39 of the NlaIII site.
‡In this and subsequent tables the copy numbers are from 20,177 tags from the resting cells.
§In this and subsequent tables the copy numbers are from 20,582 tags from the activated cells.1661 Chen et al.
cell line, HMC-1, and the basophil cell line, KU812, con-
stitutively express and secrete MIF, as shown by Western
blotting (Fig. 2 B).
At least seven proteins previously shown to mediate
secretory events in other systems, are also expressed in
RBL-2H3 cells suggesting that these components are parts
of the exocytotic machinery in mast cells as well. VAMP-2,
synaptotagmin-2 and Hrs-2 have been described as being
primarily expressed in neuronal systems and are implicated
in synaptic vesicle:plasma membrane fusion (27, 28). Both
VAMP-2 and synaptotagmin-2 (also known as v-SNAREs)
are located on vesicle membranes. The former is a compo-
nent of the minimal machinery for vesicle docking and fu-
sion, whereas the latter may function as the Ca21 sensor for
triggering synaptic vesicle fusion (29). Hrs-2 (which inter-
acts with SNAP-25), Munc-18-2 (which interacts with
syntaxins; reference 30), and complexin II (which interacts
with the SNARE complex; reference 31) have been pro-
posed to regulate synaptic vesicle exocytosis through inter-
acting with the components of SNARE complex.
Annexins are a family of structurally related proteins and
of the 13 known isoforms (32), we observed in RBL-2H3
cells transcripts for four: annexins I, II, V, and VI. New po-
tential functions of annexins are still being found (33), and
some of these may be especially relevant in mast cells. One
such is that each of these four isoforms can inhibit PLA2 ac-
tivity in vitro, and like PLA2, exhibit Ca21-dependent
binding of phospholipid in vivo. Consequently, they are
thought to act as Ca21-dependent, nonspecific inhibitors of
PLA2 by depleting substrate. Possibly, they act as counter-
balance after activation of PLA2 in stimulated mast cells.
Some annexins also mediate membrane fusion. For exam-
ple annexin I and II have been implicated in exocytosis in
neutrophil and chromaffin cells (32). In addition it has re-
cently been reported that based on lipid sequestration, an-
nexin V can act as an inhibitor of protein kinase C (34).
Finally, we observed transcripts for the receptors for two
hormones in the RBL-2H3 cells: for GnRH and for mela-
tonin. These neurohormones have direct immunomodula-
tory effects, and receptors for both have been observed on
many immune cells including T cells (35–37) but not pre-
viously on mast cells. It will be interesting to see whether
they are in fact expressed on mast cells and if so, what their
physiological function may be.
Results from Activated Cells: Upregulated Genes. When gene
expression profiles between resting and activated RBL-
2H3 cells were compared, we observed that ,1% of the
genes we analyzed were expressed at detectably different
levels in the unstimulated and stimulated cells. However,
the expression levels of several dozen genes were found to
be dramatically different between the two populations. Ta-
ble 4 lists 34 tags displaying the most significant increases
after stimulation. We estimate (Appendix) that the proba-
bilities are between 54 and 100% that the expression levels
for these genes differ by at least a factor of three for the
samples taken from the resting and activated states.
Of the 34 tags that were found to be expressed at higher
levels in the stimulated cells, three matched the genes en-
coding monocyte chemotactic protein (MCP)-1, TGF-b,
and M-CSF, in the database. The first two are among many
chemokines and cytokines previously shown to be upregu-
lated in mast cells and basophils in response to the aggrega-
tion of cell surface IgE receptors (Table 11.2 in reference
Table 3. Transcripts of Known Genes Not Previously Described in
Mast Cells
Tag sequence
Resting
cells
Activated
cells Gene
Cytokine
AACGCAGCCA 39 34 MIF*
Exocytotic machinery
CACAGCAAGG 3 4 Hrs-2‡
TTCAAGAAGT 4 3 Complexin II
AACGTTGGGA 2 2 Munc-18-2
CAAGCGAGCC 2 1 rSec6
CCCCCAATTC 2 3 Vamp-2‡
AAAATAAACT 1 1 Synaptotagmin-2
CCTCTACGAA 1 2 a-SNAP
PLA2 inhibitors
AGACACTTCC 5 3 Annexin II
AATGAAATCA 3 5 Annexin I
GCTAAGTGGC 1 3 Annexin VI
AAATTGTGAA 1 2 Annexin V‡
Receptors
TGAAAAAAAA 2 4 GnRH receptor‡
GCCCCCAGGA 1 2 Melatonin receptor‡
*Confirmed by Northern blotting, cloning, sequencing, and Western
blotting.
‡Confirmed by RT-PCR.
Figure 2. Characterization of transcripts and
their products. (A) MIF detected by RT-PCR.
Total RNAs were prepared from rat peritoneal
mast cells and macrophages and used for RT-
PCR using specific primers for rat MIF. The
marker (leftmost lane) shows the position of a
cDNA product having the expected size of 550
bp. (B) MIF detected by Western blot. Immuno-
precipitates were prepared by reacting goat poly-
clonal anti-human MIF antibodies with the mate-
rial indicated below, separated on polyacrylamide
gels, and blotted either with a mouse monoclonal
anti-human MIF antibody (lanes 1–6), or with
polyclonal rabbit anti–rat MIF antibodies (lanes
7–9). Lanes 1, 4, and 7 were loaded with lysates
from 3 3 106 HMC-1, KU812, and RBL-2H3
cells, respectively; lanes 2, 5, and 8 with 1 ml of
culture supernatants from HMC-1, KU812, and RBL-2H3 cells; lanes 3,
6, and 9 with 1 ml of the medium used to culture HMC-1, KU812, and
RBL-2H3 cells, as a control. (C) MAPKK3 detected by Western blot.
Lysates from 2 3 105 RBL-2H3 cells were blotted with anti-MAPKK3
antibody. Lane 1, Unstimulated cells. Lanes 2–5, Cells stimulated for 0.5,
3.5, 7, and 16 h.1662 Gene Expression in Mast Cells
5); expression of the third was constitutive in the human
cell line HMC-1 and up-regulated after stimulation with
phorbol ester and ionophore (38). The remaining 31 tags
represent newly identified inducible genes. Four of them
have matches in the database: cyclin G (39), adrenodoxin
(40), rVH6 (41), and preprorelaxin (42).
The sequences of the additional 27 differentially ex-
pressed tags were not identical to sequences currently in the
Table 4. Transcripts Increased in Mast Cells after FceRI Stimulation
Tag Sequences
Cells
Gene Probability Resting Activated
Known to be induced after stimulation %‡
AATACTAGAA 2 43 MCP-1§ 100
GGTGACAGGG 1 8 M-CSF 61
ATCGTGCGCT 1 7 TGF-b 54
Not known to be induced after stimulation
Tag No.
1 GTTCAGGGTC 43 410 Endogenous retrovirus-like 100
2 GAGCTGACAC 5 85 Endogenous retrovirus-like 100
3 GTGGACAGCT 9 80 Endogenous retrovirus-like 100
4 AAACTGTTTG 9 63 No match 99
5 GATCCGGAGG 3 53 No match 100
6 CAGGCAGAAA 4 41 No match 99
7 TTGATCCGGA 0 29 No match 100
8 CTTTGGGTAC 2 16 Cyclin G 81
9 GAAGCTAATA 1 16 MAPKK3 91
10 AGTTCTGCTT 1 14 No match 86
11 GTGGCTTACA 2 13 No match 69
12 AGCAAGAATT 0 10 Adrenodoxin 87
13 CTTGCTGGTC 1 10 No match 72
14 TGTCTCAGCC 0 10 No match 87
15 ACCTTGTCCT 1 9 No match 67
16 GACTGCGTCG 1 9 No match 67
17 AGCCTCCCTT 1 8 No match 61
18 GCGGGCGTCT 0 8 No match 80
19 GCTGGGCTCC 1 8 No match 61
20 GTCTCTCTTC 1 8 No match 61
21 TATTTATTCC 1 8 No match 61
22 TCATCATTCT 1 8 No match 61
23 AAACATTGGG 1 7 No match 54
24 ACACCTCCTG 0 7 No match 76
25 ACTCACAGGA 0 7 No match 76
26 CCTGATTGGG 1 7 No match 54
27 CTCGAGTTTC 0 7 No match 76
28 GGGCAATAAC 0 7 No match 76
29 GTTCATTTTG 1 7 No match 54
30 TGTTCCTTAG 0 5 rVH6, dsPTP 63
31 GATCGAAGTC 0 4 preprorelaxin 56
*The 34 tags displaying the largest increase after antigen stimulation are shown.
‡In this and the following table the percentage refers to the probability that there is at least a threefold difference in expression of the transcript in the
activated cells.
§In this and the following table, genes in boldface were confirmed by Northern blot analysis and/or cloning and sequencing.1663 Chen et al.
rat gene data bank (the last search having been conducted
in early July, 1998). Because even a single nucleotide dif-
ference will cause a sequence to be labeled as no match,
unidentified sequences could represent species variants rather
than novel genes. However, because the tags are so short
(10 specific bp) and allelic variations so infrequent, it is un-
likely that many of the “no matches” simply represent al-
lelic variants of known genes.
Further Study of Differentially Expressed Genes. It was of
obvious interest to explore further some of the differen-
tially expressed genes to see whether some of those not
represented in the sequence database (no match) could be
identified.
Tag 1 (Table 4) was chosen because it is highly expressed
in both unstimulated and stimulated cells and increases ten-
fold upon stimulation. Tag 9 was chosen somewhat at ran-
dom as typical of a sequence differentially expressed at an
intermediate level. Labeled oligos representing these tags
were used to probe Northern blots as well as an RBL-2H3
cDNA library from resting cells.
The probe from tag 1 hybridized to a 6-kb transcript on
Northern blots (data not shown) and identified a 1.5-kb
cDNA clone during screening of the library. It is likely that
this cDNA clone is derived from an endogenous retrovi-
rus-like DNA sequence since it shows significant similarity
to retroviral sequences in the database. For example it has
84% homology to a rat endogenous retroviral RAL ele-
ment (43), 83% similarity to proviral MO-VL30 in the tpl-2
locus (44) and 78% homology to the VL30 element (45).
Sequence analysis of the cDNA identified sequences of tags
2 and 3 (Table 4) just upstream of a short (8–6 bp, respec-
tively) polyadenine stretch. It is plausible that a small
amount of internal oligo dT-priming occurred at these
sites.
The cDNA cloned with a tag 9 probe is a 2.5-kb frag-
ment and represents the full transcript as confirmed by
Northern blotting (Fig. 3). It codes for rat MAPKK, a pro-
tein that had not previously been characterized in rats but
which has an amino acid sequence 99% identical to the
murine MAPKK3 protein. MAPKK3 is a member of the
MAPKK supergene family and phosphorylates and activates
p38, a member of the MAPK family (46). The original
prototypes of the MAPK family are ERK1 and 2, which
are activated by MAPKK1 and 2 through phosphorylations
on tyrosine and threonine, and inactivated via dephosphor-
ylation of either of the phosphorylated residues by MAPK
phosphatases such as CT100 and PAC1. A variety of extra-
cellular stimuli promote expression of these enzymes (47).
Other Differentially Expressed Genes. Transcription of the
recently identified ubiquitous MAPK phosphatase, rVH6,
is induced during nerve growth factor-mediated differenti-
ation in PC12 cells (41). SAGE analysis revealed its expres-
sion in RBL-2H3 cells in response to stimulation through
FceRI (Table 4). It is interesting to speculate that this is
linked to the contemporaneous induction of MAPKK3.
A gene whose upregulation was unanticipated was that
for preprorelaxin (Table 4). This preprohormone structur-
ally belongs to the preproinsulin family and it is primarily
produced by corpora lutea (48). Relaxin’s well character-
ized function is to inhibit uterine contraction and to con-
tribute to the remodeling and softening of tissues in the
birth canal during pregnancy (49, 50). Among its other bi-
ological activities, it has been reported to inhibit the release
of histamine by mast cells in vitro (51), and to alleviate ex-
perimental allergic asthma in vivo (52). Since we have now
shown it to be upregulated in mast cells after stimulation
(Table 4 and Fig. 3), it will be particularly interesting to ex-
plore its role in mast cell physiology.
Table 5 lists the nine tags whose expression showed the
largest decrease when the RBL cells were stimulated. The
only sequence that matched with a citation in the rat data-
base was for RMCP-5. Its decreased expression after stimu-
lation was confirmed by Northern blotting (Fig. 3).
Some genes or gene products that were previously
shown to be upregulated in activated mast cells were not
found in either of our SAGE libraries. There are several
possible explanations for this apparent discrepancy: (a) since
in various published studies a variety of mast cell lines, cul-
tured mast cells, and different tissue mast cells were exam-
ined, any individual cell line may not display the full heter-
ogeneity that characterizes the different cell preparations;
(b) different studies employed different times and doses of
antigen than used here; (c) if the expression of a gene was
low we may not have observed it since in order to detect a
transcript with 95% probability, there would have had to
be on the average, 23 copies of it per cell in either popula-
tion (Appendix); (d) some unanticipated deficiency in the
generation of the SAGE libraries.
Figure 3. Northern blots of selected genes. Messenger RNAs were
prepared and used for Northern blotting with end-labeled 15–40-bp oli-
gonucleotides in all cases except for RMCP-5; for the latter a randomly
labeled PCR-amplified cDNA was used. The b-actin blot is a loading
control. The columns to the left of the blots list the copy numbers of the
tags observed in the resting and activated SAGE libraries for the indicated
genes. MKK3 refers to MAPKK3.1664 Gene Expression in Mast Cells
To distinguish between possibilities c and d, we used
RT-PCR to compare with preprorelaxin, the expression
of two representative transcripts (TNF-a and IL-3) that
were not revealed in our SAGE libraries. PCR amplifica-
tion for each transcript was performed for a variable num-
ber of thermal cycles. To assure that spurious differences in
amplification were not generated, b-actin was used as a
control. Fig. 4 shows that the b-actin transcript was ob-
served after only 14 cycles and that there was no apprecia-
ble difference between the resting and activated cells. Tran-
scripts of preprorelaxin were readily observed after 18
cycles and were clearly upregulated in the stimulated cells.
TNF-a has previously been shown to be constitutively
present and upregulated, but at the time we chose to pre-
pare the library from stimulated cells (3.5 h), the observed
enhancement was modest consistent with our RT-PCR
results (compare our Fig. 4 with Fig. 3 in reference 53).
However, it took 30 cycles for the TNF-a transcript to
reach the level attained by preprorelaxin after only 22 cycles.
The prior study showed that the level of IL-3 transcripts
was enhanced after receptor-mediated activation but was
on the decline when probed at 4 h; in our study, the level
of PCR product observed on the photograph of the gel af-
ter 30 cycles was so low that it would not have reproduced
adequately, and we saw no enhancement in the PCR
product prepared from the mRNA of the cells activated for
3.5 h (data not shown). This result indicates that the level
of expression of some upregulated genes may have been
below the threshold necessary for us to have detected it by
the SAGE analysis.
Discussion
The term transcriptome has been coined to describe the
identity and multiplicity of mRNAs expressed by a defined
population of cells (21). The object of the work described
in this paper was to begin to define such a profile for mast
cells before and after stimulation of the cells by one of their
important cell surface receptors, FceRI. To get sufficient
amounts of material (mRNA) we used a rodent mucosal
mast cell line, RBL-2H3, even though we recognize that
findings on the RBL-2H3 cells will ultimately need to be
extended explicitly to their normal counterparts and to hu-
man cells. Clearly, this extension can be carried out much
more incisively on the basis of the initial work on the rat
cell line as has already proven to be the case with respect to
FceRI and many other molecules and phenomena first
studied in this cell line.
We obtained a partial transcriptome of RBL-2H3 cells
by generating .40,000 tags derived from transcripts of
resting and activated cells using the SAGE method. The re-
sults of the analysis provided a quantitative overview of the
expression of 11,300 genes in the RBL-2H3 cells. Al-
though the more limited sequences in the rat database may
have precluded immediate identification of many of these
tags, this is clearly a temporary situation and the genes en-
coding a significant number of the tags have already been
identified. In this section we discuss briefly several of our
new findings that we think are of special interest.
MIF. The observation that mRNA for MIF, a cyto-
kine not previously associated with mast cells, is expressed
constitutively in high amounts is interesting. MIF was first
identified 30 yr ago as a soluble factor that is produced by
activated lymphocytes (T cells) and that inhibits the ran-
dom migration of cultured macrophages. Recent studies
have identified macrophages and cells of the anterior pituitary
as additional important sources of production of MIF (26). In
both cases, MIF is found in preformed granules and is released
in response to inflammatory stimuli such as lipopolysaccharide
(54, 55). We found that like macrophages and pituitary cells,
RBL-2H3 cells, normal peritoneal mast cells, the human mast
cell line HMC-1, and the human basophil cell line KU812,
constitutively express MIF at high levels.
The high level expression of MIF in mast cells provides
further evidence that host defense is a major function of
these cells and suggests that MIF is one of the mediators.
Direct evidence that mast cells play an important role in
host defense comes from two studies using mast cell-defi-
cient W/Wv mice. The mortality for mast cell-deficient
Table 5. Transcripts Decreased in Mast Cells after
FceRI Stimulation*
Tag sequence
Cells
Gene Probability Resting Activated
TGATCTTTTT 11 1 No match
%
76
TTGTATAATA 10 1 '' 72
TTCATTCATG 9 1 '' 67
TGCAGTCATC 8 0 '' 80
TGGAAGGACC 8 0 '' ''
GAGACTTGCT 7 0 '' 76
GCCAAATTTG 7 0 '' ''
GGGGTAAGAG 7 0 '' ''
TGGGATCTGG 7 0 RMCP-5 ''
*The nine tags displaying the largest decrease in expression after stimu-
lation as shown.
Figure 4. Results of RT-PCR amplification of mRNAs from resting
and activated cells using primers specific for selected transcripts. Items
shown as “nt” were not tested.1665 Chen et al.
W/Wv mice after challenge with virulent bacteria is signifi-
cantly higher than their litter mate controls (56, 57) and
their reconstitution with cultured mast cells restores their
resistance to infection.
Mast cell-derived TNF-a is a crucial mediator in this re-
sponse by recruiting bactericidal leukocytes, but other fac-
tor(s) may contribute since exogenous TNF-a only par-
tially restores the host protection mediated by mast cells.
Potentially, MIF fills this role. It activates macrophages to
produce TNF-a and nitrous oxide (58), and thus may con-
tribute to the development of an inflammatory response, a
critical element of innate immunity. It would be interesting
to explore to what extent simultaneous administration of
exogenous MIF and TNF-a into mast cell–deficient W/Wv
mice would restore host protection against infection to a
level equivalent to that provided by mast cells.
It is noteworthy that hyperplasia of mast cells and high
levels of MIF have been observed in synovium from patients
with rheumatoid arthritis and that administration of antibod-
ies capable of neutralizing MIF delayed the onset of arthritis
in a mouse model (59–61). These observations may relate to
the central role MIF is thought to play in delayed-type hy-
persensitivity (DTH). Thus, MIF mRNA and protein are
expressed in DTH lesions and neutralizing anti-MIF anti-
bodies significantly inhibit the development of DTH (62).
Mast cells have been long been implicated in DTH. The
best evidence is defective elicitation of DTH in W/Wv and
SI/SId mast cell–deficient mice, and restoration of the
DTH response after adoptive transfer of cultured mast cells
into these mice (63). Our finding that both mast cells and
macrophages are important sources of MIF, may relate to
the two types of DTH that have been observed: mast cell–
dependent DTH as in footpad DTH, and macrophage-
dependent DTH as in classic tuberculin DTH (64).
Exocytotic Machinery. Aggregation of FceRI causes an
increase in the intracellular concentration of Ca21 and an
activation of protein kinase C—two events that are re-
quired for mediator release (65). Although several low mo-
lecular weight GTPases have been implicated in the process
(66, 67), many of the molecular components of the mast
cell exocytotic machinery remain unknown.
In this study, we found that RBL-2H3 cells express at
least seven proteins known to be involved in exocytosis in
other systems, particularly at nerve terminals. According to
the SNARE hypothesis (27), four proteins constitute the
core exocytotic machinery at the nerve terminal: synap-
totagmin and VAMP (v-SNAREs) on the vesicle mem-
brane, SNAP-25, and syntaxin (t-SNAREs) on the target
membrane. Two cytosolic proteins (NSF and SNAP) are
involved in the recycling of vesicles after fusion. The process
is believed to be regulated by other proteins such as Hrs-2,
complex II, and Munc-18 due to their ability to interact
with the core complex. Finding that these proteins are
common to neurons and mast cells (see Results) suggest
they play similar roles in the two systems.
Neurohormone Receptors. There is increasing evidence
for an integrated bidirectionally-regulated interaction be-
tween the neuroendocrine and immune systems (68). For
example, both systems express and respond to a variety of
common regulatory molecules (neuropeptides, cytokines,
and steroids). In this study, we uncovered another example
for such an interaction by finding that mast cells, like cells
of the pituitary, express MIF, as well as mRNA for the re-
ceptors for GnRH and melatonin. By regulating gonadal
steroids the hypothalamic hormone GnRH modulates im-
mune responses indirectly but it can also influence such re-
sponses directly by stimulating proliferation of T and B
cells through their receptors for GnRH (35, 69, 70). Simi-
larly, melatonin, produced in the pineal gland of the hypo-
thalamus, has immunoregulatory properties: it can activate
monocytes and neutrophils (36), and induce proliferation
of T cells and their release of cytokines (37).
Other Differentially Expressed Genes. We anticipated that
the genes for MCP-1, M-CSF, and TGF-b would be in-
duced in the activated cells (5). Of these, MCP-1 deserves
special attention because treatment with anti-MCP-1 anti-
body reduces recruitment of monocytes by 65% during the
development of a late phase allergic reaction in humans (5).
The high level of expression (Z650 copies/cell) of MCP-1
mRNA in activated RBL-2H3 cells, and its persistence (at
least 24 h), is consistent with its having an important role in
the delayed reaction.
Among the inducible genes, MAPKK3 is also particu-
larly interesting. Because they are involved in the regula-
tion of such a diverse array of cellular process, MAPK cas-
cades have attracted considerable attention in the past 10 yr
(46). The kinases are themselves regulated by phosphoryla-
tion/dephosphorylation. In the RBL cells, both the mRNA
and protein for MAPKK3 are increased more than tenfold
after activation. This response is specific and other mem-
bers of the MAPK family, such as MAPKK 1, 2, and 5
were not differentially expressed in the resting and acti-
vated states in RBL-2H3 cells (data not shown). It will be
interesting to determine the physiological consequence of
increases in the MAPKK3 protein after activation.
In recent years, the changes in expression of genes in ac-
tivated mast cells have been actively pursued. The standard
methods such as Northern blotting (71), RT-PCR (53),
and subtraction libraries (72) have been used in such stud-
ies. Although several dozens of cytokines, chemokines, and
other immunomodulatory molecules have been shown to
be upregulated after activation (5), such methods can ana-
lyze only limited numbers of genes in a single study and the
quantitative analysis of the transcription of individual genes
is difficult. We have found that the SAGE method is partic-
ularly useful for such studies and in this initial investigation
have already uncovered a rich trove of expressed genes, ex-
ploration of whose function is likely to give further insight
into the physiology of mast cells.
Appendix
Detecting a Transcript. Assume that a single cell contains
300,000 transcripts, that each transcript has an equal chance
of detection, and that 20,000 tags are generated for each of
two cell lines. Then a specific mRNA with an average1666 Gene Expression in Mast Cells
(mean) of N transcripts in each cell line will generate on
average a total of T 5 N/7.5 tags. Assuming a Poisson dis-
tribution on the total number of tags actually generated,
the probability that no tags are seen is e-T, which is z5%
when T 5 3. Thus a transcript that appears a mean of 22.5
times in two cell lines, i.e., at an average abundance of
0.0075%, has a 95% chance of being detected.
Changes in Levels of Expression.  In activated and resting
cells respectively, assume that A and B copies are found of a
tag corresponding to a particular mRNA species. We wish
to calculate the probability that the expression of this
mRNA has increased by a factor of at least F. This problem
is best approached through Bayesian statistical analysis
(chapter 8 in reference 73). Assume that given the actual
concentration of the mRNA in the activated and resting
cells, the expected numbers of tags generated by the exper-
iment are Y and Z, respectively, and let x 5 Y/(Y1Z).
The variable x takes on a value between 0 and 1, and we
need to assume a prior probability distribution (i.e., before
observing A and B) for x. For mathematical convenience, it
is easiest to choose this distribution from among the two-
parameter family of beta distributions (chapter 6 in refer-
ence 73). The beta distribution with parameters a and b has
a probability density function
(1)
where a and b are both positive real numbers, G is the
gamma function and x ranges as stated from 0 to 1. With
beta (a, b) as the prior, Bayesian analysis (details omitted)
implies that after observing A and B tags respectively from
activated and resting cells, the posterior probability density
for x is simply beta (A 1 a, B 1 b). Assuming we generated
an approximately equal number of tags for both resting and
fx () Gab + ()
G a () Gb ()
---------------------------- x
a 1 –
1 x – ()
b 1 –
=
activated cells, for the mRNA expression to be increased
by a factor of at least F, x must fall between F/(F 1 1) and
1. We may calculate this probability simply by integrating
beta (A 1 a, B 1 b) from F/(F 1 1) to 1.
For a specific experiment, we need to choose appropri-
ate values for the parameters a and b. So-called “uninfor-
mative” priors use a 5 b 5 1, for which the beta distribu-
tion reduces to the uniform distribution over the interval
[0,1]. However, in this experiment our data suggest the ex-
pression levels of most genes do not differ greatly in resting
and activated cells, similar to what has been observed when
normal and cancerous cells were compared (7, 74). Thus
our prior distribution should not be uniform but should be
peaked near 0.05. This corresponds to a beta distribution
with parameters a and b equal, and greater than 1. The
larger the value of the parameters a and b, the greater the
concentration of the prior probability for x near 0.5, and
the more evidence that is needed to infer a given change in
the level of expression. For detectable mRNA species, the
complete set of ordered pairs representing the number of
tags observed in resting and activated cells (data not
shown), implies a reasonable choice for the parameters a
and b is 2.0. 
We apply this analysis to calculate the probability P that
the level of expression of a given mRNA species has been
increased by at least threefold. Assuming the prior distribu-
tion beta (2,2), and noting that for positive integral values
of n, G (n) 5 (n 2 1)!, we have
(2)
This equation is used to produce the probabilities in Tables
4 and 5.
P AB3 ++ ()
A 1 + () ! B 1 + () !
-------------------------------------------- x
A 1 +
0.75
1.0 ò 1 x – ()
B 1 + dx. =
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